Hwail Pharmaceutical Co.,Ltd. (KOSDAQ:061250)
South Korea · Delayed Price · Currency is KRW 5,450.00
+50.00 (0.93%)
At close: Nov 13, 2026
Hwail Pharmaceutical Market Cap
Hwail Pharmaceutical has a market cap or net worth of 45.86 billion as of November 13, 2026. It is the 32,761st most valuable company in the world and the 1,848th biggest in South Korea. Its market cap has decreased by 51.66% in one year.
Market Cap
45.86B
Enterprise Value
-43.74B
Revenue
107.87B
Global Rank
Country Rank
#1,848 South Korea
PE Ratio
11.49
ChartMarket Cap Chart
Since March 3, 2003, Hwail Pharmaceutical's market cap has increased from 24.67B to 45.86B, an increase of 85.84%. That is a compound annual growth rate of 2.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 45.86B | -52.80% |
| Dec 30, 2025 | 97.15B | -6.85% |
| Dec 30, 2024 | 104.30B | -27.25% |
| Dec 28, 2023 | 143.36B | -22.49% |
| Dec 29, 2022 | 184.96B | 7.56% |
| Dec 30, 2021 | 171.96B | -31.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Optipharm.CO.,LTD | 64.25B |
| Sinsin Pharmaceutical | 58.41B |
| GL Pharm Tech | 51.18B |
| BL Pharmtech | 47.25B |
| RP Bio | 46.28B |
| Jin Yang Pharmaceutical | 43.38B |
| GeneBioTech Co. ,Ltd | 43.23B |
| Eagle Veterinary Technology Co.,Ltd | 36.41B |